ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global BRAF Kinase Inhibitors Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-3D1256
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global BRAF Kinase Inhibitors Market Insights Forecast to 2028
BUY CHAPTERS

Global BRAF Kinase Inhibitors Market Insights, Forecast to 2030

Code: QYRE-Auto-3D1256
Report
December 2024
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Array BioPharma Inc
Bayer
F Hoffmann La Roche Ltd
Novartis

BRAF Kinase Inhibitors Market

BRAF kinase inhibitors are generally used as targeted therapy drugs for the treatment of carcinomas such as RCC, NSCLC, and melanomas caused by mutations of the BRAF gene.
The global BRAF Kinase Inhibitors market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
These drugs directly target BRAF protein and inhibit the growth of tumors in patients with metastatic melanoma. Such results delivered by the BRAF kinase inhibitors has encouraged several R&D teams to extend research on other applications. Moreover, many BRAF kinase inhibitor drugs are in the final stages of development and are expected to be launched during the forecast period.
Report Covers:
This report presents an overview of global market for BRAF Kinase Inhibitors, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of BRAF Kinase Inhibitors, also provides the sales of main regions and countries. Highlights of the upcoming market potential for BRAF Kinase Inhibitors, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the BRAF Kinase Inhibitors sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global BRAF Kinase Inhibitors market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for BRAF Kinase Inhibitors sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of BRAF Kinase Inhibitors Market Report

Report Metric Details
Report Name BRAF Kinase Inhibitors Market
Segment by Type
Segment by Application
  • Hospital
  • Medical Research Institute
  • Clinic
  • Other
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company F. Hoffmann-La Roche Ltd., Novartis AG
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of BRAF Kinase Inhibitors in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of BRAF Kinase Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, BRAF Kinase Inhibitors sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the BRAF Kinase Inhibitors Market report?

Ans: The main players in the BRAF Kinase Inhibitors Market are F. Hoffmann-La Roche Ltd., Novartis AG

What are the Application segmentation covered in the BRAF Kinase Inhibitors Market report?

Ans: The Applications covered in the BRAF Kinase Inhibitors Market report are Hospital, Medical Research Institute, Clinic, Other

What are the Type segmentation covered in the BRAF Kinase Inhibitors Market report?

Ans: The Types covered in the BRAF Kinase Inhibitors Market report are Dabrafenib, Sorafenib, Vemurafenib, Encorafenib

Recommended Reports

Kinase Inhibitors

Cancer Drug Inhibitors

Cancer & Melanoma Therapies

1 Study Coverage
1.1 BRAF Kinase Inhibitors Product Introduction
1.2 Market by Type
1.2.1 Global BRAF Kinase Inhibitors Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Dabrafenib
1.2.3 Sorafenib
1.2.4 Vemurafenib
1.2.5 Encorafenib
1.3 Market by Application
1.3.1 Global BRAF Kinase Inhibitors Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Medical Research Institute
1.3.4 Clinic
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global BRAF Kinase Inhibitors Sales Estimates and Forecasts 2019-2030
2.2 Global BRAF Kinase Inhibitors Revenue by Region
2.2.1 Global BRAF Kinase Inhibitors Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global BRAF Kinase Inhibitors Revenue by Region (2019-2024)
2.2.3 Global BRAF Kinase Inhibitors Revenue by Region (2025-2030)
2.2.4 Global BRAF Kinase Inhibitors Revenue Market Share by Region (2019-2030)
2.3 Global BRAF Kinase Inhibitors Sales Estimates and Forecasts 2019-2030
2.4 Global BRAF Kinase Inhibitors Sales by Region
2.4.1 Global BRAF Kinase Inhibitors Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global BRAF Kinase Inhibitors Sales by Region (2019-2024)
2.4.3 Global BRAF Kinase Inhibitors Sales by Region (2025-2030)
2.4.4 Global BRAF Kinase Inhibitors Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global BRAF Kinase Inhibitors Sales by Manufacturers
3.1.1 Global BRAF Kinase Inhibitors Sales by Manufacturers (2019-2024)
3.1.2 Global BRAF Kinase Inhibitors Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of BRAF Kinase Inhibitors in 2023
3.2 Global BRAF Kinase Inhibitors Revenue by Manufacturers
3.2.1 Global BRAF Kinase Inhibitors Revenue by Manufacturers (2019-2024)
3.2.2 Global BRAF Kinase Inhibitors Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by BRAF Kinase Inhibitors Revenue in 2023
3.3 Global Key Players of BRAF Kinase Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global BRAF Kinase Inhibitors Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global BRAF Kinase Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of BRAF Kinase Inhibitors, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of BRAF Kinase Inhibitors, Product Offered and Application
3.8 Global Key Manufacturers of BRAF Kinase Inhibitors, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global BRAF Kinase Inhibitors Sales by Type
4.1.1 Global BRAF Kinase Inhibitors Historical Sales by Type (2019-2024)
4.1.2 Global BRAF Kinase Inhibitors Forecasted Sales by Type (2025-2030)
4.1.3 Global BRAF Kinase Inhibitors Sales Market Share by Type (2019-2030)
4.2 Global BRAF Kinase Inhibitors Revenue by Type
4.2.1 Global BRAF Kinase Inhibitors Historical Revenue by Type (2019-2024)
4.2.2 Global BRAF Kinase Inhibitors Forecasted Revenue by Type (2025-2030)
4.2.3 Global BRAF Kinase Inhibitors Revenue Market Share by Type (2019-2030)
4.3 Global BRAF Kinase Inhibitors Price by Type
4.3.1 Global BRAF Kinase Inhibitors Price by Type (2019-2024)
4.3.2 Global BRAF Kinase Inhibitors Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global BRAF Kinase Inhibitors Sales by Application
5.1.1 Global BRAF Kinase Inhibitors Historical Sales by Application (2019-2024)
5.1.2 Global BRAF Kinase Inhibitors Forecasted Sales by Application (2025-2030)
5.1.3 Global BRAF Kinase Inhibitors Sales Market Share by Application (2019-2030)
5.2 Global BRAF Kinase Inhibitors Revenue by Application
5.2.1 Global BRAF Kinase Inhibitors Historical Revenue by Application (2019-2024)
5.2.2 Global BRAF Kinase Inhibitors Forecasted Revenue by Application (2025-2030)
5.2.3 Global BRAF Kinase Inhibitors Revenue Market Share by Application (2019-2030)
5.3 Global BRAF Kinase Inhibitors Price by Application
5.3.1 Global BRAF Kinase Inhibitors Price by Application (2019-2024)
5.3.2 Global BRAF Kinase Inhibitors Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada BRAF Kinase Inhibitors Market Size by Type
6.1.1 US & Canada BRAF Kinase Inhibitors Sales by Type (2019-2030)
6.1.2 US & Canada BRAF Kinase Inhibitors Revenue by Type (2019-2030)
6.2 US & Canada BRAF Kinase Inhibitors Market Size by Application
6.2.1 US & Canada BRAF Kinase Inhibitors Sales by Application (2019-2030)
6.2.2 US & Canada BRAF Kinase Inhibitors Revenue by Application (2019-2030)
6.3 US & Canada BRAF Kinase Inhibitors Market Size by Country
6.3.1 US & Canada BRAF Kinase Inhibitors Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada BRAF Kinase Inhibitors Sales by Country (2019-2030)
6.3.3 US & Canada BRAF Kinase Inhibitors Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe BRAF Kinase Inhibitors Market Size by Type
7.1.1 Europe BRAF Kinase Inhibitors Sales by Type (2019-2030)
7.1.2 Europe BRAF Kinase Inhibitors Revenue by Type (2019-2030)
7.2 Europe BRAF Kinase Inhibitors Market Size by Application
7.2.1 Europe BRAF Kinase Inhibitors Sales by Application (2019-2030)
7.2.2 Europe BRAF Kinase Inhibitors Revenue by Application (2019-2030)
7.3 Europe BRAF Kinase Inhibitors Market Size by Country
7.3.1 Europe BRAF Kinase Inhibitors Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe BRAF Kinase Inhibitors Sales by Country (2019-2030)
7.3.3 Europe BRAF Kinase Inhibitors Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China BRAF Kinase Inhibitors Market Size
8.1.1 China BRAF Kinase Inhibitors Sales (2019-2030)
8.1.2 China BRAF Kinase Inhibitors Revenue (2019-2030)
8.2 China BRAF Kinase Inhibitors Market Size by Application
8.2.1 China BRAF Kinase Inhibitors Sales by Application (2019-2030)
8.2.2 China BRAF Kinase Inhibitors Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia BRAF Kinase Inhibitors Market Size by Type
9.1.1 Asia BRAF Kinase Inhibitors Sales by Type (2019-2030)
9.1.2 Asia BRAF Kinase Inhibitors Revenue by Type (2019-2030)
9.2 Asia BRAF Kinase Inhibitors Market Size by Application
9.2.1 Asia BRAF Kinase Inhibitors Sales by Application (2019-2030)
9.2.2 Asia BRAF Kinase Inhibitors Revenue by Application (2019-2030)
9.3 Asia BRAF Kinase Inhibitors Sales by Region
9.3.1 Asia BRAF Kinase Inhibitors Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia BRAF Kinase Inhibitors Revenue by Region (2019-2030)
9.3.3 Asia BRAF Kinase Inhibitors Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America BRAF Kinase Inhibitors Market Size by Type
10.1.1 Middle East, Africa and Latin America BRAF Kinase Inhibitors Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America BRAF Kinase Inhibitors Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America BRAF Kinase Inhibitors Market Size by Application
10.2.1 Middle East, Africa and Latin America BRAF Kinase Inhibitors Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America BRAF Kinase Inhibitors Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America BRAF Kinase Inhibitors Sales by Country
10.3.1 Middle East, Africa and Latin America BRAF Kinase Inhibitors Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America BRAF Kinase Inhibitors Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America BRAF Kinase Inhibitors Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Array BioPharma Inc.
11.1.1 Array BioPharma Inc. Company Information
11.1.2 Array BioPharma Inc. Overview
11.1.3 Array BioPharma Inc. BRAF Kinase Inhibitors Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Array BioPharma Inc. BRAF Kinase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Array BioPharma Inc. Recent Developments
11.2 Bayer AG
11.2.1 Bayer AG Company Information
11.2.2 Bayer AG Overview
11.2.3 Bayer AG BRAF Kinase Inhibitors Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Bayer AG BRAF Kinase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer AG Recent Developments
11.3 F. Hoffmann-La Roche Ltd.
11.3.1 F. Hoffmann-La Roche Ltd. Company Information
11.3.2 F. Hoffmann-La Roche Ltd. Overview
11.3.3 F. Hoffmann-La Roche Ltd. BRAF Kinase Inhibitors Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 F. Hoffmann-La Roche Ltd. BRAF Kinase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.4 Novartis AG
11.4.1 Novartis AG Company Information
11.4.2 Novartis AG Overview
11.4.3 Novartis AG BRAF Kinase Inhibitors Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Novartis AG BRAF Kinase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis AG Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 BRAF Kinase Inhibitors Industry Chain Analysis
12.2 BRAF Kinase Inhibitors Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 BRAF Kinase Inhibitors Production Mode & Process
12.4 BRAF Kinase Inhibitors Sales and Marketing
12.4.1 BRAF Kinase Inhibitors Sales Channels
12.4.2 BRAF Kinase Inhibitors Distributors
12.5 BRAF Kinase Inhibitors Customers
13 Market Dynamics
13.1 BRAF Kinase Inhibitors Industry Trends
13.2 BRAF Kinase Inhibitors Market Drivers
13.3 BRAF Kinase Inhibitors Market Challenges
13.4 BRAF Kinase Inhibitors Market Restraints
14 Key Findings in The Global BRAF Kinase Inhibitors Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Array BioPharma Inc
Bayer
F Hoffmann La Roche Ltd
Novartis
List of Tables
    Table 1. Global BRAF Kinase Inhibitors Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Dabrafenib
    Table 3. Major Manufacturers of Sorafenib
    Table 4. Major Manufacturers of Vemurafenib
    Table 5. Major Manufacturers of Encorafenib
    Table 6. Global BRAF Kinase Inhibitors Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global BRAF Kinase Inhibitors Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 8. Global BRAF Kinase Inhibitors Revenue by Region (2019-2024) & (US$ Million)
    Table 9. Global BRAF Kinase Inhibitors Revenue by Region (2025-2030) & (US$ Million)
    Table 10. Global BRAF Kinase Inhibitors Revenue Market Share by Region (2019-2024)
    Table 11. Global BRAF Kinase Inhibitors Revenue Market Share by Region (2025-2030)
    Table 12. Global BRAF Kinase Inhibitors Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 13. Global BRAF Kinase Inhibitors Sales by Region (2019-2024) & (K Liter)
    Table 14. Global BRAF Kinase Inhibitors Sales by Region (2025-2030) & (K Liter)
    Table 15. Global BRAF Kinase Inhibitors Sales Market Share by Region (2019-2024)
    Table 16. Global BRAF Kinase Inhibitors Sales Market Share by Region (2025-2030)
    Table 17. Global BRAF Kinase Inhibitors Sales by Manufacturers (2019-2024) & (K Liter)
    Table 18. Global BRAF Kinase Inhibitors Sales Share by Manufacturers (2019-2024)
    Table 19. Global BRAF Kinase Inhibitors Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 20. Global BRAF Kinase Inhibitors Revenue Share by Manufacturers (2019-2024)
    Table 21. Global Key Players of BRAF Kinase Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
    Table 22. BRAF Kinase Inhibitors Price by Manufacturers 2019-2024 (USD/Liter)
    Table 23. Global BRAF Kinase Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global BRAF Kinase Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BRAF Kinase Inhibitors as of 2023)
    Table 25. Global Key Manufacturers of BRAF Kinase Inhibitors, Manufacturing Base Distribution and Headquarters
    Table 26. Global Key Manufacturers of BRAF Kinase Inhibitors, Product Offered and Application
    Table 27. Global Key Manufacturers of BRAF Kinase Inhibitors, Date of Enter into This Industry
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global BRAF Kinase Inhibitors Sales by Type (2019-2024) & (K Liter)
    Table 30. Global BRAF Kinase Inhibitors Sales by Type (2025-2030) & (K Liter)
    Table 31. Global BRAF Kinase Inhibitors Sales Share by Type (2019-2024)
    Table 32. Global BRAF Kinase Inhibitors Sales Share by Type (2025-2030)
    Table 33. Global BRAF Kinase Inhibitors Revenue by Type (2019-2024) & (US$ Million)
    Table 34. Global BRAF Kinase Inhibitors Revenue by Type (2025-2030) & (US$ Million)
    Table 35. Global BRAF Kinase Inhibitors Revenue Share by Type (2019-2024)
    Table 36. Global BRAF Kinase Inhibitors Revenue Share by Type (2025-2030)
    Table 37. BRAF Kinase Inhibitors Price by Type (2019-2024) & (USD/Liter)
    Table 38. Global BRAF Kinase Inhibitors Price Forecast by Type (2025-2030) & (USD/Liter)
    Table 39. Global BRAF Kinase Inhibitors Sales by Application (2019-2024) & (K Liter)
    Table 40. Global BRAF Kinase Inhibitors Sales by Application (2025-2030) & (K Liter)
    Table 41. Global BRAF Kinase Inhibitors Sales Share by Application (2019-2024)
    Table 42. Global BRAF Kinase Inhibitors Sales Share by Application (2025-2030)
    Table 43. Global BRAF Kinase Inhibitors Revenue by Application (2019-2024) & (US$ Million)
    Table 44. Global BRAF Kinase Inhibitors Revenue by Application (2025-2030) & (US$ Million)
    Table 45. Global BRAF Kinase Inhibitors Revenue Share by Application (2019-2024)
    Table 46. Global BRAF Kinase Inhibitors Revenue Share by Application (2025-2030)
    Table 47. BRAF Kinase Inhibitors Price by Application (2019-2024) & (USD/Liter)
    Table 48. Global BRAF Kinase Inhibitors Price Forecast by Application (2025-2030) & (USD/Liter)
    Table 49. US & Canada BRAF Kinase Inhibitors Sales by Type (2019-2024) & (K Liter)
    Table 50. US & Canada BRAF Kinase Inhibitors Sales by Type (2025-2030) & (K Liter)
    Table 51. US & Canada BRAF Kinase Inhibitors Revenue by Type (2019-2024) & (US$ Million)
    Table 52. US & Canada BRAF Kinase Inhibitors Revenue by Type (2025-2030) & (US$ Million)
    Table 53. US & Canada BRAF Kinase Inhibitors Sales by Application (2019-2024) & (K Liter)
    Table 54. US & Canada BRAF Kinase Inhibitors Sales by Application (2025-2030) & (K Liter)
    Table 55. US & Canada BRAF Kinase Inhibitors Revenue by Application (2019-2024) & (US$ Million)
    Table 56. US & Canada BRAF Kinase Inhibitors Revenue by Application (2025-2030) & (US$ Million)
    Table 57. US & Canada BRAF Kinase Inhibitors Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 58. US & Canada BRAF Kinase Inhibitors Revenue by Country (2019-2024) & (US$ Million)
    Table 59. US & Canada BRAF Kinase Inhibitors Revenue by Country (2025-2030) & (US$ Million)
    Table 60. US & Canada BRAF Kinase Inhibitors Sales by Country (2019-2024) & (K Liter)
    Table 61. US & Canada BRAF Kinase Inhibitors Sales by Country (2025-2030) & (K Liter)
    Table 62. Europe BRAF Kinase Inhibitors Sales by Type (2019-2024) & (K Liter)
    Table 63. Europe BRAF Kinase Inhibitors Sales by Type (2025-2030) & (K Liter)
    Table 64. Europe BRAF Kinase Inhibitors Revenue by Type (2019-2024) & (US$ Million)
    Table 65. Europe BRAF Kinase Inhibitors Revenue by Type (2025-2030) & (US$ Million)
    Table 66. Europe BRAF Kinase Inhibitors Sales by Application (2019-2024) & (K Liter)
    Table 67. Europe BRAF Kinase Inhibitors Sales by Application (2025-2030) & (K Liter)
    Table 68. Europe BRAF Kinase Inhibitors Revenue by Application (2019-2024) & (US$ Million)
    Table 69. Europe BRAF Kinase Inhibitors Revenue by Application (2025-2030) & (US$ Million)
    Table 70. Europe BRAF Kinase Inhibitors Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 71. Europe BRAF Kinase Inhibitors Revenue by Country (2019-2024) & (US$ Million)
    Table 72. Europe BRAF Kinase Inhibitors Revenue by Country (2025-2030) & (US$ Million)
    Table 73. Europe BRAF Kinase Inhibitors Sales by Country (2019-2024) & (K Liter)
    Table 74. Europe BRAF Kinase Inhibitors Sales by Country (2025-2030) & (K Liter)
    Table 75. China BRAF Kinase Inhibitors Sales by Type (2019-2024) & (K Liter)
    Table 76. China BRAF Kinase Inhibitors Sales by Type (2025-2030) & (K Liter)
    Table 77. China BRAF Kinase Inhibitors Revenue by Type (2019-2024) & (US$ Million)
    Table 78. China BRAF Kinase Inhibitors Revenue by Type (2025-2030) & (US$ Million)
    Table 79. China BRAF Kinase Inhibitors Sales by Application (2019-2024) & (K Liter)
    Table 80. China BRAF Kinase Inhibitors Sales by Application (2025-2030) & (K Liter)
    Table 81. China BRAF Kinase Inhibitors Revenue by Application (2019-2024) & (US$ Million)
    Table 82. China BRAF Kinase Inhibitors Revenue by Application (2025-2030) & (US$ Million)
    Table 83. Asia BRAF Kinase Inhibitors Sales by Type (2019-2024) & (K Liter)
    Table 84. Asia BRAF Kinase Inhibitors Sales by Type (2025-2030) & (K Liter)
    Table 85. Asia BRAF Kinase Inhibitors Revenue by Type (2019-2024) & (US$ Million)
    Table 86. Asia BRAF Kinase Inhibitors Revenue by Type (2025-2030) & (US$ Million)
    Table 87. Asia BRAF Kinase Inhibitors Sales by Application (2019-2024) & (K Liter)
    Table 88. Asia BRAF Kinase Inhibitors Sales by Application (2025-2030) & (K Liter)
    Table 89. Asia BRAF Kinase Inhibitors Revenue by Application (2019-2024) & (US$ Million)
    Table 90. Asia BRAF Kinase Inhibitors Revenue by Application (2025-2030) & (US$ Million)
    Table 91. Asia BRAF Kinase Inhibitors Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 92. Asia BRAF Kinase Inhibitors Revenue by Region (2019-2024) & (US$ Million)
    Table 93. Asia BRAF Kinase Inhibitors Revenue by Region (2025-2030) & (US$ Million)
    Table 94. Asia BRAF Kinase Inhibitors Sales by Region (2019-2024) & (K Liter)
    Table 95. Asia BRAF Kinase Inhibitors Sales by Region (2025-2030) & (K Liter)
    Table 96. Middle East, Africa and Latin America BRAF Kinase Inhibitors Sales by Type (2019-2024) & (K Liter)
    Table 97. Middle East, Africa and Latin America BRAF Kinase Inhibitors Sales by Type (2025-2030) & (K Liter)
    Table 98. Middle East, Africa and Latin America BRAF Kinase Inhibitors Revenue by Type (2019-2024) & (US$ Million)
    Table 99. Middle East, Africa and Latin America BRAF Kinase Inhibitors Revenue by Type (2025-2030) & (US$ Million)
    Table 100. Middle East, Africa and Latin America BRAF Kinase Inhibitors Sales by Application (2019-2024) & (K Liter)
    Table 101. Middle East, Africa and Latin America BRAF Kinase Inhibitors Sales by Application (2025-2030) & (K Liter)
    Table 102. Middle East, Africa and Latin America BRAF Kinase Inhibitors Revenue by Application (2019-2024) & (US$ Million)
    Table 103. Middle East, Africa and Latin America BRAF Kinase Inhibitors Revenue by Application (2025-2030) & (US$ Million)
    Table 104. Middle East, Africa and Latin America BRAF Kinase Inhibitors Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 105. Middle East, Africa and Latin America BRAF Kinase Inhibitors Revenue by Country (2019-2024) & (US$ Million)
    Table 106. Middle East, Africa and Latin America BRAF Kinase Inhibitors Revenue by Country (2025-2030) & (US$ Million)
    Table 107. Middle East, Africa and Latin America BRAF Kinase Inhibitors Sales by Country (2019-2024) & (K Liter)
    Table 108. Middle East, Africa and Latin America BRAF Kinase Inhibitors Sales by Country (2025-2030) & (K Liter)
    Table 109. Array BioPharma Inc. Company Information
    Table 110. Array BioPharma Inc. Description and Major Businesses
    Table 111. Array BioPharma Inc. BRAF Kinase Inhibitors Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
    Table 112. Array BioPharma Inc. BRAF Kinase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. Array BioPharma Inc. Recent Developments
    Table 114. Bayer AG Company Information
    Table 115. Bayer AG Description and Major Businesses
    Table 116. Bayer AG BRAF Kinase Inhibitors Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
    Table 117. Bayer AG BRAF Kinase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. Bayer AG Recent Developments
    Table 119. F. Hoffmann-La Roche Ltd. Company Information
    Table 120. F. Hoffmann-La Roche Ltd. Description and Major Businesses
    Table 121. F. Hoffmann-La Roche Ltd. BRAF Kinase Inhibitors Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
    Table 122. F. Hoffmann-La Roche Ltd. BRAF Kinase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. F. Hoffmann-La Roche Ltd. Recent Developments
    Table 124. Novartis AG Company Information
    Table 125. Novartis AG Description and Major Businesses
    Table 126. Novartis AG BRAF Kinase Inhibitors Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
    Table 127. Novartis AG BRAF Kinase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. Novartis AG Recent Developments
    Table 129. Key Raw Materials Lists
    Table 130. Raw Materials Key Suppliers Lists
    Table 131. BRAF Kinase Inhibitors Distributors List
    Table 132. BRAF Kinase Inhibitors Customers List
    Table 133. BRAF Kinase Inhibitors Market Trends
    Table 134. BRAF Kinase Inhibitors Market Drivers
    Table 135. BRAF Kinase Inhibitors Market Challenges
    Table 136. BRAF Kinase Inhibitors Market Restraints
    Table 137. Research Programs/Design for This Report
    Table 138. Key Data Information from Secondary Sources
    Table 139. Key Data Information from Primary Sources
List of Figures
    Figure 1. BRAF Kinase Inhibitors Product Picture
    Figure 2. Global BRAF Kinase Inhibitors Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global BRAF Kinase Inhibitors Market Share by Type in 2023 & 2030
    Figure 4. Dabrafenib Product Picture
    Figure 5. Sorafenib Product Picture
    Figure 6. Vemurafenib Product Picture
    Figure 7. Encorafenib Product Picture
    Figure 8. Global BRAF Kinase Inhibitors Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global BRAF Kinase Inhibitors Market Share by Application in 2023 & 2030
    Figure 10. Hospital
    Figure 11. Medical Research Institute
    Figure 12. Clinic
    Figure 13. Other
    Figure 14. BRAF Kinase Inhibitors Report Years Considered
    Figure 15. Global BRAF Kinase Inhibitors Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global BRAF Kinase Inhibitors Revenue 2019-2030 (US$ Million)
    Figure 17. Global BRAF Kinase Inhibitors Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 18. Global BRAF Kinase Inhibitors Revenue Market Share by Region (2019-2030)
    Figure 19. Global BRAF Kinase Inhibitors Sales 2019-2030 ((K Liter)
    Figure 20. Global BRAF Kinase Inhibitors Sales Market Share by Region (2019-2030)
    Figure 21. US & Canada BRAF Kinase Inhibitors Sales YoY (2019-2030) & (K Liter)
    Figure 22. US & Canada BRAF Kinase Inhibitors Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. Europe BRAF Kinase Inhibitors Sales YoY (2019-2030) & (K Liter)
    Figure 24. Europe BRAF Kinase Inhibitors Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. China BRAF Kinase Inhibitors Sales YoY (2019-2030) & (K Liter)
    Figure 26. China BRAF Kinase Inhibitors Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Asia (excluding China) BRAF Kinase Inhibitors Sales YoY (2019-2030) & (K Liter)
    Figure 28. Asia (excluding China) BRAF Kinase Inhibitors Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. Middle East, Africa and Latin America BRAF Kinase Inhibitors Sales YoY (2019-2030) & (K Liter)
    Figure 30. Middle East, Africa and Latin America BRAF Kinase Inhibitors Revenue YoY (2019-2030) & (US$ Million)
    Figure 31. The BRAF Kinase Inhibitors Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 32. The Top 5 and 10 Largest Manufacturers of BRAF Kinase Inhibitors in the World: Market Share by BRAF Kinase Inhibitors Revenue in 2023
    Figure 33. Global BRAF Kinase Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 34. Global BRAF Kinase Inhibitors Sales Market Share by Type (2019-2030)
    Figure 35. Global BRAF Kinase Inhibitors Revenue Market Share by Type (2019-2030)
    Figure 36. Global BRAF Kinase Inhibitors Sales Market Share by Application (2019-2030)
    Figure 37. Global BRAF Kinase Inhibitors Revenue Market Share by Application (2019-2030)
    Figure 38. US & Canada BRAF Kinase Inhibitors Sales Market Share by Type (2019-2030)
    Figure 39. US & Canada BRAF Kinase Inhibitors Revenue Market Share by Type (2019-2030)
    Figure 40. US & Canada BRAF Kinase Inhibitors Sales Market Share by Application (2019-2030)
    Figure 41. US & Canada BRAF Kinase Inhibitors Revenue Market Share by Application (2019-2030)
    Figure 42. US & Canada BRAF Kinase Inhibitors Revenue Share by Country (2019-2030)
    Figure 43. US & Canada BRAF Kinase Inhibitors Sales Share by Country (2019-2030)
    Figure 44. U.S. BRAF Kinase Inhibitors Revenue (2019-2030) & (US$ Million)
    Figure 45. Canada BRAF Kinase Inhibitors Revenue (2019-2030) & (US$ Million)
    Figure 46. Europe BRAF Kinase Inhibitors Sales Market Share by Type (2019-2030)
    Figure 47. Europe BRAF Kinase Inhibitors Revenue Market Share by Type (2019-2030)
    Figure 48. Europe BRAF Kinase Inhibitors Sales Market Share by Application (2019-2030)
    Figure 49. Europe BRAF Kinase Inhibitors Revenue Market Share by Application (2019-2030)
    Figure 50. Europe BRAF Kinase Inhibitors Revenue Share by Country (2019-2030)
    Figure 51. Europe BRAF Kinase Inhibitors Sales Share by Country (2019-2030)
    Figure 52. Germany BRAF Kinase Inhibitors Revenue (2019-2030) & (US$ Million)
    Figure 53. France BRAF Kinase Inhibitors Revenue (2019-2030) & (US$ Million)
    Figure 54. U.K. BRAF Kinase Inhibitors Revenue (2019-2030) & (US$ Million)
    Figure 55. Italy BRAF Kinase Inhibitors Revenue (2019-2030) & (US$ Million)
    Figure 56. Russia BRAF Kinase Inhibitors Revenue (2019-2030) & (US$ Million)
    Figure 57. China BRAF Kinase Inhibitors Sales Market Share by Type (2019-2030)
    Figure 58. China BRAF Kinase Inhibitors Revenue Market Share by Type (2019-2030)
    Figure 59. China BRAF Kinase Inhibitors Sales Market Share by Application (2019-2030)
    Figure 60. China BRAF Kinase Inhibitors Revenue Market Share by Application (2019-2030)
    Figure 61. Asia BRAF Kinase Inhibitors Sales Market Share by Type (2019-2030)
    Figure 62. Asia BRAF Kinase Inhibitors Revenue Market Share by Type (2019-2030)
    Figure 63. Asia BRAF Kinase Inhibitors Sales Market Share by Application (2019-2030)
    Figure 64. Asia BRAF Kinase Inhibitors Revenue Market Share by Application (2019-2030)
    Figure 65. Asia BRAF Kinase Inhibitors Revenue Share by Region (2019-2030)
    Figure 66. Asia BRAF Kinase Inhibitors Sales Share by Region (2019-2030)
    Figure 67. Japan BRAF Kinase Inhibitors Revenue (2019-2030) & (US$ Million)
    Figure 68. South Korea BRAF Kinase Inhibitors Revenue (2019-2030) & (US$ Million)
    Figure 69. China Taiwan BRAF Kinase Inhibitors Revenue (2019-2030) & (US$ Million)
    Figure 70. Southeast Asia BRAF Kinase Inhibitors Revenue (2019-2030) & (US$ Million)
    Figure 71. India BRAF Kinase Inhibitors Revenue (2019-2030) & (US$ Million)
    Figure 72. Middle East, Africa and Latin America BRAF Kinase Inhibitors Sales Market Share by Type (2019-2030)
    Figure 73. Middle East, Africa and Latin America BRAF Kinase Inhibitors Revenue Market Share by Type (2019-2030)
    Figure 74. Middle East, Africa and Latin America BRAF Kinase Inhibitors Sales Market Share by Application (2019-2030)
    Figure 75. Middle East, Africa and Latin America BRAF Kinase Inhibitors Revenue Market Share by Application (2019-2030)
    Figure 76. Middle East, Africa and Latin America BRAF Kinase Inhibitors Revenue Share by Country (2019-2030)
    Figure 77. Middle East, Africa and Latin America BRAF Kinase Inhibitors Sales Share by Country (2019-2030)
    Figure 78. Brazil BRAF Kinase Inhibitors Revenue (2019-2030) & (US$ Million)
    Figure 79. Mexico BRAF Kinase Inhibitors Revenue (2019-2030) & (US$ Million)
    Figure 80. Turkey BRAF Kinase Inhibitors Revenue (2019-2030) & (US$ Million)
    Figure 81. Israel BRAF Kinase Inhibitors Revenue (2019-2030) & (US$ Million)
    Figure 82. GCC Countries BRAF Kinase Inhibitors Revenue (2019-2030) & (US$ Million)
    Figure 83. BRAF Kinase Inhibitors Value Chain
    Figure 84. BRAF Kinase Inhibitors Production Process
    Figure 85. Channels of Distribution
    Figure 86. Distributors Profiles
    Figure 87. Bottom-up and Top-down Approaches for This Report
    Figure 88. Data Triangulation
    Figure 89. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global BRAF Inhibitors Market Research Report 2024
Global BRAF V600E Kinase Inhibitors Market Research Report 2024
Global Targeted Therapy Drugs for Melanoma Market Research Report 2024
Global Kinase Inhibitors For Cancer Treatment Market Research Report 2024
Global Combination Therapy with BRAF and MEK Inhibitors Market Research Report 2024
Global ALK Inhibitors Market Research Report 2024
Global Saracatinib Market Research Report 2024
Global Kinase Inhibitors Market Insights Forecast to 2030
Global Melanoma Drugs Market Insights Forecast to 2030
Global MEK Inhibitor Market Research Report 2024
Global Tyrosine Kinase Inhibitors Market Research Report 2024
Global KRAS Inhibitor Market Research Report 2024
Global Ceritinib Capsules Market Research Report 2024
Global Anaplastic Lymphoma Kinase Inhibitors Market Insights Forecast to 2030
Small Molecule Inhibitors for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Targeted Drug BRAF Inhibitors for NSCLC Market Research Report 2024
Sorafenib Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anaplastic Lymphoma Kinase ALK Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pazopanib Drugs Market Research Report 2024
Global Pazopanib API Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions